The cooperation between hMena overexpression and HER2 signalling in breast cancer - Wikidata - awgldk - TriplyDB

The cooperation between hMena overexpression and HER2 signalling in breast cancer

The cooperation between hMena overexpression and HER2 signalling in breast cancer

http://www.wikidata.org/entity/Q33786779

about

Filopodia and adhesion in cancer cell motility Human breast cancer metastases to the brain display GABAergic properties in the neural niche.An attempt at a molecular prediction of metastasis in patients with primary cutaneous melanoma.Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma.hMENA(11a), a hMENA isoform sending survival signals.The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome.Aptamers and their potential to selectively target aspects of EGF, Wnt/β-catenin and TGFβ-smad family signaling.MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer.hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.ATM kinase sustains HER2 tumorigenicity in breast cancer.Regulation of VASP by phosphorylation: consequences for cell migration.Emerging roles for LPP in metastatic cancer progression.hMena: altered expression in psoriatic skin.Design and Stereoselective Synthesis of ProM-2: A Spirocyclic Diproline Mimetic with Polyproline Type II (PPII) Helix Conformation.

P2860

Q26823315-3BECDA4C-84AC-4F86-A163-10ABB1FDDF6A Q30569512-F8495BF1-5932-4C34-83BC-649593F8D774 Q34482829-D2FF1947-9EF1-4475-AE38-7DED0875EF1E Q34957141-1D173F4A-17FF-499A-B3E3-1FEAC50CDDF6 Q35963802-2C6EBCFE-8ADF-4A55-83C6-0281C55383FB Q36436933-8273EB19-478F-4B19-8BCE-AAB17D736982 Q36557418-84BB1B17-AB62-47EB-8E44-676F2DD2E405 Q36998423-9FFD6B04-B551-4B7C-A1ED-CB2C7A06E399 Q37557707-52FF2190-BEA1-4DDC-AF4B-1B25F08D26DD Q38093337-E17CED1C-D1EF-4CEF-8261-103930036AEE Q38733113-47260086-5788-48CB-87AD-28C030C03BE4 Q38876630-9017B952-6F55-46CF-82DA-6BCD0991AE1C Q38886304-1DABD207-9B4A-472D-9ADB-86A3B7746855 Q41920997-BC42D04F-0914-48ED-A6CE-1FD3590F7A2B Q47658713-26CC5C32-A954-44CB-9912-600701D05E8D Q51055101-BB5574C7-74CF-4CA9-B66C-C372942A13F2 Q52867387-B1E50B3E-9272-466E-803B-5B23790B70F4

P2860

The cooperation between hMena overexpression and HER2 signalling in breast cancer

http://www.wikidata.org/entity/Q33786779

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The cooperation between hMena overexpression and HER2 signalling in breast cancer

@ast

The cooperation between hMena overexpression and HER2 signalling in breast cancer

@en

type

label

The cooperation between hMena overexpression and HER2 signalling in breast cancer

@ast

The cooperation between hMena overexpression and HER2 signalling in breast cancer

@en

prefLabel

The cooperation between hMena overexpression and HER2 signalling in breast cancer

@ast

The cooperation between hMena overexpression and HER2 signalling in breast cancer

@en

P1433

Q33786779-69C9306B-A998-4769-A7E8-359D07279B56

P1476

Q33786779-6D8F67C0-9968-4DCA-99FA-AC2EEC3BABA0

P2093

Q33786779-177AE065-EE2B-4F3C-8B0D-273998066517

Q33786779-6D3083E3-13DD-4EE9-B37B-1EEA754A61A3

Q33786779-A680B7FE-33CF-46DB-A6CF-4FDEF03FFDD3

Q33786779-A8443A03-7C8D-42FB-8973-59C287426E86

Q33786779-CD8E71CF-C75E-4461-A439-7B93A4829342

Q33786779-D8D376E6-4075-43CC-BA55-094950DED50B

Q33786779-D9D54115-E686-4656-90AF-2A8D89ECDBD7

Q33786779-EE452509-1C03-41E9-AC73-CFF4715D85E5

P2860

Q33786779-1117970F-F0BA-47DE-9390-89E9A512E019

Q33786779-1BADC8AC-489C-4D72-8D4C-B721DC8D193C

Q33786779-1F6B5F3B-1600-4912-A3D0-A8F2B659C72B

Q33786779-28E77D65-E676-45BE-9864-439219C8546D

Q33786779-2B5816BD-D7F8-4425-AADD-5D68715FD0D6

Q33786779-3C03C1B8-F29F-47A6-8FA3-3209F70A4646

Q33786779-58875C75-F348-4C34-ACC8-1072B28B10EB

Q33786779-5B62846D-DF04-4D39-BC28-28EA101F02E8

Q33786779-5F2FE3A8-3C02-4B0C-AC8D-A7EC8D3C88EB

Q33786779-633196D1-52F2-47F0-B8E4-A55DE3953091

P304

Q33786779-FF3895A1-5931-4BB3-A047-C18D96B94139

P31

Q33786779-1BA962E4-278A-4F37-8BC8-F10809176781

P356

Q33786779-39EC1032-AF16-4643-9905-06B429A4B467

P407

Q33786779-0403B0CB-0FA3-4833-8608-441AA1C66339

P433

Q33786779-B335B759-0951-4F98-B9CD-0CF0BED40E7A

P478

Q33786779-D99F2222-BCC2-4550-9D59-B281E7619E0C

P50

Q33786779-42BB6456-F45B-46B7-BFE5-20F91483F99D

Q33786779-5B5014B4-2D42-4279-83EE-5F7BC222C556

Q33786779-836F3D05-749D-497B-A349-3E77BFCCA2CA

Q33786779-8E8A383B-A28A-4997-97F5-EDB2E5BC8A11

Q33786779-A268526C-AC52-4210-974C-DF7BCD30557C

Q33786779-D5966409-719D-4FA2-AA66-A3A373E1A47B

Q33786779-F4F01261-AF7E-4A24-989D-0678CC2BFC69

P577

Q33786779-8A54FE6B-B650-459A-AD2D-BDF85905C08F

P5875

Q33786779-B671BCC7-D840-4F8C-965E-E368C88E263B

P698

Q33786779-C5737901-A766-412A-94E9-451970DD041B

P921

Q33786779-772FB2DC-C1E1-4F1E-9838-1372028B9A9F

P932

Q33786779-3C2AFF2C-C4C6-4D99-B179-38F59111744C

P356

JOURNAL.PONE.0015852

P1433

P1476

The cooperation between hMena overexpression and HER2 signalling in breast cancer

@en

P2093

Andrea Conidi

http://www.w3.org/2001/XMLSchema#string

Angela Santoni

http://www.w3.org/2001/XMLSchema#string

Francesca Belleudi

http://www.w3.org/2001/XMLSchema#string

Lucia DeMonte

http://www.w3.org/2001/XMLSchema#string

Marcella Mottolese

http://www.w3.org/2001/XMLSchema#string

Maria Rosaria Torrisi

http://www.w3.org/2001/XMLSchema#string

Paola Nisticò

http://www.w3.org/2001/XMLSchema#string

Paola Trono

http://www.w3.org/2001/XMLSchema#string

P2860

ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1

Tes, a specific Mena interacting partner, breaks the rules for EVH1 binding

Molecular portraits of human breast tumours

The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation

Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response

EGF-ERBB signalling: towards the systems level

Ena/VASP proteins can regulate distinct modes of actin organization at cadherin-adhesive contacts.

Pigment epithelium-derived factor is differentially expressed in peripheral neuropathies.

P304

e15852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0015852

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Irene Terrenato

Marcella Mottolese

Massimo Alessio

Francesca Di Modugno

Michele Balsamo

P577

2010-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49732271

http://www.w3.org/2001/XMLSchema#string

P698

21209853

http://www.w3.org/2001/XMLSchema#string

P921

P932

3012725

http://www.w3.org/2001/XMLSchema#string